Bank Of Nova Scotia Merck & Co., Inc. Transaction History
Bank Of Nova Scotia
- $47.4 Billion
- Q3 2024
A detailed history of Bank Of Nova Scotia transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bank Of Nova Scotia holds 1,214,293 shares of MRK stock, worth $117 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
1,214,293
Previous 805,828
50.69%
Holding current value
$117 Million
Previous $99.8 Million
38.23%
% of portfolio
0.29%
Previous 0.18%
Shares
15 transactions
Others Institutions Holding MRK
# of Institutions
3,821Shares Held
1.88BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.1 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.5 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.3 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.7 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $244B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...